유럽의 흉터 관리 시장 : 분석 및 예측(2023-2030년)

Introduction to Europe Scar Management Market

The Europe scar management market was valued at $238.5 million in 2023 and is anticipated to reach $351.0 million by 2030, witnessing a CAGR of 5.67% during the forecast period 2023-2030. The expansion of the scar management market in Europe is anticipated to be propelled by the rising prevalence of scars resulting from surgeries, accidents, and burns, leading to heightened demand for effective management solutions.

Market Introduction

The scar management market in Europe is characterized by continuous innovation and an increasing emphasis on treating scars caused by surgeries, injuries, or skin problems. The market is expanding rapidly in response to increased demand for effective scar management treatments, such as atrophic, hypertrophic, keloid, contracture scars, and stretch marks.

Regulatory developments, combined with ongoing research and collaboration among medical professionals and industry stakeholders, are propelling the scar management market in Europe. These initiatives indicate a promising future as the market evolves to meet the changing needs of customers looking for scar enhancement options.

However, challenges such as navigating complex regulatory frameworks and guaranteeing the affordability and accessibility of innovative medicines remain. Nonetheless, the market provides significant potential for companies to differentiate themselves by developing unique goods and therapies that use technological improvements and ongoing research initiatives.

Overall, the scar management market in Europe is primed for growth and transition, owing to rising awareness, shifting consumer preferences, and a relentless pursuit of more effective scar-enhancing products.

Market Segmentation:

Segmentation 1: by Product

• Silicon Gel and Spray
• Silicon Dressing
• Cream and Ointment
• Others

Segmentation 2: by Scar Type

• Atrophic Scars
• Hypertrophic and Keloid Scars
• Others

Segmentation 3: by End User

• Hospitals
• Specialty Clinics
• Home Healthcare (Over-the-Counter (OTC))

Segmentation 4: by Region

• Europe - Germany, U.K., France, Spain, Italy, Portugal, Netherlands, Ireland, Belgium, Switzerland, Norway, Denmark, Sweden, Finland, Czech Republic, Russian Federation, Poland, Austria, Romania, Slovakia, Greece, Turkiye, and Ukraine

How can this report add value to an organization?

Workflow/Innovation Strategy: The Europe scar management market (by scar type) comprises atrophic scars, hypertrophic and keloid scars, contracture scars, and stretch marks. Moreover, the study provides the reader with a detailed understanding of the various types of scars and associated products tailored to address these scars.

Growth/Marketing Strategy: The Europe scar management market's growth strategy includes innovation, expansion into emerging markets, collaboration with healthcare professionals, and regulatory streamlining. These efforts aim to enhance accessibility and meet the diverse needs of consumers.

Competitive Strategy: Key players in the Europe scar management market have been analyzed and profiled in the study, including new product launches and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe scar management market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some prominent names established in this market are:

• Advancis Medical
• Bayer AG
• B. Braun S.E.
• Molnlycke Health Care AB
• Smith & Nephew
• Stratpharma AG

Table of Contents

Executive Summary

Scope of the Report

Research Methodology

1 Market

• 1.1 Product Definition
• 1.2 Inclusion Criteria for the Report
• 1.3 Exclusion Criteria for the Report
• 1.4 Key Findings

2 Industry Outlook

• 2.1 Market Overview
• 2.2 Market Trends
• 2.3 Impact of COVID-19 on Scar Management
• 2.4 Supply Chain Analysis
  • 2.4.1 Key Entities in Supply Chain
• 2.5 Purchasing Channels
• 2.6 Reimbursement Scenario
  • 2.6.1 Reimbursement Scenario in Europe

3 Europe

• 3.1 Overview
• 3.2 Europe
  • 3.2.1 Legal Framework and Regulatory Requirement
  • 3.2.2 Market Dynamics
  • 3.2.3 Market Sizing and Forecast
    • 3.2.3.1 Europe Scar Management Market (by Product)
    • 3.2.3.2 Europe Scar Management Market (by Scar Type)
    • 3.2.3.3 Europe Scar Management Market (by End User)
    • 3.2.3.4 Europe Scar Management Market, (by Country)
      • 3.2.3.4.1 Germany
        • 3.2.3.4.1.1 Market Dynamics
        • 3.2.3.4.1.2 Market Sizing and Forecast
        • 3.2.3.4.1.2.1 Germany Scar Management Market (by Product)
      • 3.2.3.4.2 France
        • 3.2.3.4.2.1 Market Dynamics
        • 3.2.3.4.2.2 Market Sizing and Forecast
        • 3.2.3.4.2.2.1 France Scar Management Market (by Product)
      • 3.2.3.4.3 U.K.
        • 3.2.3.4.3.1 Market Dynamics
        • 3.2.3.4.3.2 Market Sizing and Forecast
        • 3.2.3.4.3.2.1 U.K. Scar Management Market (by Product)
      • 3.2.3.4.4 Italy
        • 3.2.3.4.4.1 Market Dynamics
        • 3.2.3.4.4.2 Market Sizing and Forecast
        • 3.2.3.4.4.2.1 Italy Scar Management Market (by Product)
      • 3.2.3.4.5 Spain
        • 3.2.3.4.5.1 Market Dynamics
        • 3.2.3.4.5.2 Market Sizing and Forecast
        • 3.2.3.4.5.2.1 Spain Scar Management Market (by Product)
      • 3.2.3.4.6 Portugal
        • 3.2.3.4.6.1 Market Dynamics
        • 3.2.3.4.6.2 Market Sizing and Forecast
        • 3.2.3.4.6.2.1 Portugal Scar Management Market (by Product)
      • 3.2.3.4.7 Netherlands
        • 3.2.3.4.7.1 Market Dynamics
        • 3.2.3.4.7.2 Market Sizing and Forecast
        • 3.2.3.4.7.2.1 Netherland Scar Management Market (by Product)
      • 3.2.3.4.8 Ireland
        • 3.2.3.4.8.1 Market Dynamics
        • 3.2.3.4.8.2 Market Sizing and Forecast
        • 3.2.3.4.8.2.1 Ireland Scar Management Market (by Product)
      • 3.2.3.4.9 Belgium
        • 3.2.3.4.9.1 Market Dynamics
        • 3.2.3.4.9.2 Market Sizing and Forecast
        • 3.2.3.4.9.2.1 Belgium Scar Management Market (by Product)
      • 3.2.3.4.10 Switzerland
        • 3.2.3.4.10.1 Market Dynamics
        • 3.2.3.4.10.2 Market Sizing and Forecast
        • 3.2.3.4.10.2.1 Switzerland Scar Management Market (by Product)
      • 3.2.3.4.11 Norway
        • 3.2.3.4.11.1 Market Dynamics
        • 3.2.3.4.11.2 Market Sizing and Forecast
        • 3.2.3.4.11.2.1 Norway Scar Management Market (by Product)
      • 3.2.3.4.12 Denmark
        • 3.2.3.4.12.1 Market Dynamics
        • 3.2.3.4.12.2 Market Sizing and Forecast
        • 3.2.3.4.12.2.1 Denmark Scar Management Market (by Product)
      • 3.2.3.4.13 Sweden
        • 3.2.3.4.13.1 Market Dynamics
        • 3.2.3.4.13.2 Market Sizing and Forecast
        • 3.2.3.4.13.2.1 Sweden Scar Management Market (by Product)
      • 3.2.3.4.14 Finland
        • 3.2.3.4.14.1 Market Dynamics
        • 3.2.3.4.14.2 Market Sizing and Forecast
        • 3.2.3.4.14.2.1 Finland Scar Management Market (by Product)
      • 3.2.3.4.15 Czech Republic
        • 3.2.3.4.15.1 Market Dynamics
        • 3.2.3.4.15.2 Market Size and Forecast
        • 3.2.3.4.15.2.1 Czech Republic Scar Management Market (by Product)
      • 3.2.3.4.16 Russian Federation
        • 3.2.3.4.16.1 Market Dynamics
        • 3.2.3.4.16.2 Market Size and Forecast
        • 3.2.3.4.16.2.1 Russia Federation Scar Management Market (by Product)
      • 3.2.3.4.17 Poland
        • 3.2.3.4.17.1 Market Dynamics
        • 3.2.3.4.17.2 Market Size and Forecast
        • 3.2.3.4.17.2.1 Poland Scar Management Market (by Product)
      • 3.2.3.4.18 Austria
        • 3.2.3.4.18.1 Market Dynamics
        • 3.2.3.4.18.2 Market Size and Forecast
        • 3.2.3.4.18.2.1 Austria Scar Management Market (by Product)
      • 3.2.3.4.19 Romania
        • 3.2.3.4.19.1 Market Dynamics
        • 3.2.3.4.19.2 Market Size and Forecast
        • 3.2.3.4.19.2.1 Romania Scar Management Market (by Product)
      • 3.2.3.4.20 Slovakia
        • 3.2.3.4.20.1 Market Dynamics
        • 3.2.3.4.20.2 Market Size and Forecast
        • 3.2.3.4.20.2.1 Slovakia Scar Management Market (by Product)
      • 3.2.3.4.21 Greece
        • 3.2.3.4.21.1 Market Dynamics
        • 3.2.3.4.21.2 Market Size and Forecast
        • 3.2.3.4.21.2.1 Greece Scar Management Market (by Product)
      • 3.2.3.4.22 Turkiye
        • 3.2.3.4.22.1 Market Dynamics
        • 3.2.3.4.22.2 Market Size and Forecast
        • 3.2.3.4.22.2.1 Turkiye Scar Management Market (by Product)
      • 3.2.3.4.23 Ukraine
        • 3.2.3.4.23.1 Market Dynamics
        • 3.2.3.4.23.2 Market Size and Forecast
        • 3.2.3.4.23.2.1 Ukraine Scar Management Market (by Product)

4 Markets - Competitive Benchmarking & Company Profiles

• 4.1 Competitive Landscape
  • 4.1.1 Overview
  • 4.1.2 Business Strategies
    • 4.1.2.1 Product Launches/Approvals
• 4.2 Scar Management Ecosystem Active Players
• 4.3 Company Profiles
  • 4.3.1 Advancis Medical
    • 4.3.1.1 Company Overview
    • 4.3.1.2 Role of Advancis Medical in the Scar Management Market
    • 4.3.1.3 Analyst Perspectives
  • 4.3.2 Bayer AG
    • 4.3.2.1 Company Overview
    • 4.3.2.2 Role of Bayer AG in the Scar Management Market
    • 4.3.2.3 Financials
    • 4.3.2.4 Target Customers
    • 4.3.2.5 Analyst Perspectives
  • 4.3.3 B. Braun S.E.
    • 4.3.3.1 Company Overview
    • 4.3.3.2 Role of B. Braun S.E. in the Scar Management Market
    • 4.3.3.3 Financials
    • 4.3.3.4 Target Customers
    • 4.3.3.5 Analyst Perspectives
  • 4.3.4 Molnlycke Health Care AB
    • 4.3.4.1 Company Overview
    • 4.3.4.2 Role of Molnlycke Health Care AB in the Scar Management Market
    • 4.3.4.3 Financials
    • 4.3.4.4 Target Customers
    • 4.3.4.5 Analyst Perspectives
  • 4.3.5 Smith & Nephew
    • 4.3.5.1 Company Overview
    • 4.3.5.2 Role of Smith & Nephew in the Scar Management Market
    • 4.3.5.3 Financials
    • 4.3.5.4 Target Customers
    • 4.3.5.5 Analyst Perspectives
  • 4.3.6 Stratpharma AG
    • 4.3.6.1 Company Overview
    • 4.3.6.2 Role of Stratpharma AG in the Scar Management Market
    • 4.3.6.3 Target Customers
    • 4.3.6.4 Analyst Perspectives